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doi:10.1016/j.jtcvs.2007.08.071Objective: Extravascular trafficking of leukocytes into organs is thought to play a ma-
jor role in the pathophysiologic mechanisms of the inflammatory response to cardio-
pulmonary bypass, yet leukocyte extravasation is difficult to study clinically. Here we
have tested the hypothesis that leukocyte emigration into skin blisters can provide
a way to monitor the inflammatory effect of cardiopulmonary bypass that allows test-
ing of anti-inflammatory interventions (exemplified by aprotinin).
Methods: Patients undergoing primary elective coronary artery bypass grafting (n 5
14) were randomized into 2 equal groups to receive saline infusion during cardiopul-
monary bypass (control group) or high-dose aprotinin. Experimental skin blisters (in
duplicate) were induced on the forearm by means of topical application of the vesicant
cantharidin, and blister fluid was sampled at 5 hours postoperatively. Inflammatory
leukocyte subsets in blister fluid were analyzed by means of flow cytometry by using
expression of CD11b and CD62L as a phenotypic marker of activation.
Results: In the control group of patients, cardiopulmonary bypass surgery triggered
a 381% increase in leukocyte extravasation into the skin compared with reference blis-
ters carried out before surgical intervention, with neutrophil (P 5 .014), monocyte
(P 5 .014), and eosinophil (P 5 .009) levels all statistically significantly increased.
In the aprotiningroup therewasno statistically significant increase during cardiopulmo-
nary bypass surgery in any inflammatory leukocyte subset. The activation phenotype
of extravascular leukocytes was not significantly altered between surgical groups.
Conclusions: This study introduces the cantharidin blister technique as a powerful new
research tool for analyzing the inflammatory effect of cardiopulmonary bypass in vivo.
It has provided detailed molecular insight into the extravascular leukocyte population
during cardiopulmonary bypass. Although aprotinin blocked cardiopulmonary
bypass–dependent extravasation of leukocytes, there was no change in their CD11b/
CD62L activation status. The cantharidin skin test thus represents a novel research
tool for evaluating future anti-inflammatory interventions in cardiothoracic surgery.
I
nflammation is the physiologic response to localized injury or infection and is
characterized by vasodilation, increased permeability, and extravasation of
inflammatory leukocytes into the affected tissue. However, a pathologic inflam-
matory response is triggered systemically during cardiothoracic surgery with cardio-
pulmonary bypass (CPB) because of contact activation of blood components by the
artificial bypass circuit and can result in leukocyte infiltration and harmful cytokine
secretion within susceptible organs, including the lung, kidney, and brain.1 There is
increasing evidence that neurocognitive deficit after surgical intervention is linked
to systemic inflammation,2-4 with a causal relationship between leukocyte infiltration
and central nervous system injury demonstrated in animals.5,6
Measurement of inflammatory markers in blood or urine provides little insight into
the population of leukocytes that migrates extravascularly. Leukocyte extravasation in
human subjects is difficult to study, with no controlled in vivo model for monitoring
this process. The literature has relied mainly on animal studies of induced peritonitisThe Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 5 999
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or microscopic analysis of leukocytes trafficking into animal
tissues by means of intravital microscopy. However, canthar-
idin skin blisters have been recently described as a way to
study leukocyte trafficking into an organ supplied by the sys-
temic circulation and might thus provide a useful transla-
tional tool for monitoring the clinical inflammatory
response to surgical intervention.7
Cantharidin has been in clinical use since the 1970s and is
used as a topical treatment for molluscum cantagiosum and
warts. It is a protein phosphatase 1 and 2 a inhibitor.8 When
applied to skin, it causes acantholysis and blister formation.9
No serious adverse reactions for topical use of cantharidin
have been reported in the literature.10,11 The experimental
use of cantharidin as amodel to study leukocyte trafficking in-
volves topical application of cantharidin at one seventh the
clinical dose to the forearm, causing a blister (median volume,
0.5mL) to form.7Blister fluid sampled at 24 hours exhibits the
hallmarks of acute inflammation, with infiltration of inflam-
matory leukocytes and accretion of inflammatory cytokines,
such as interleukin (IL) 8 and tumor necrosis factor (TNF)
a.We have further refined this technique to allow comprehen-
sive analysis of the surface phenotype on emigrated leuko-
cytes to be performed by means of flow cytometry.12,13
Aprotinin (Trasylol; Bayer Pharmaceuticals Corp, West
Haven, Conn) is the only US Food and Drug Administra-
tion–licensed pharmacologic agent for limiting transfusion
requirement in cardiothoracic surgery and is reported to pos-
sess clinical anti-inflammatory properties.14-18 In vitro and
animal work has suggested that its anti-inflammatory proper-
ties might be mediated, at least in part, through blockade of
leukocyte extravasation.19-22 In the present study we have
used aprotinin as a model anti-inflammatory regimen to ad-
dress the hypothesis that cantharidin skin blisters can be
used to monitor anti-inflammatory intervention in coronary
artery bypass grafting (CABG) surgery with CPB.
Our approach was to randomize patients undergoing pri-
mary elective CABG surgery with CPB into 2 groups: a con-
trol group receiving saline and an anti-inflammatory
intervention group receiving full-dose aprotinin (‘‘Hammer-
smith dose’’) during surgical intervention. Skin blisters in
duplicate were sampled at 5 hours after the operation and
compared between treatment groups. Further comparisons
were made to reference blisters carried out before that oper-
ation, which were identical in all respects except for the1000 The Journal of Thoracic and Cardiovascular Surgery c Mabsence of surgical intervention. This study design allowed
us to test the hypothesis that CPB causes enhanced leukocyte
extravasation into skin and that cantharidin blisters can be




Cantharidin (Cantharone) was purchased from Dormer Laboratories
Inc (Rexdale,Ontario, Canada). Anti-CD62L–fluorescein isothiocya-
nate, anti-CD11b–R-phycoerythrin, control IgG– fluorescein isothio-
cyanate, and control IgG–R-phycoerythrin were purchased from BD
Biosciences (Oxford, United Kingdom). Anti-CD14–phycoerythrin-
Texas red conjugate and control IgG–phycoerythrin-Texas red
conjugate were purchased from Beckman Coulter (High Wycombe,
United Kingdom).
Patients
Institutional review board approval for the study protocol was
gained from the Hammersmith, Queen Charlottes, and Chelsea
Research Ethics Committee. Patients referred for elective CABG
were enrolled after providing informed consent, and the study was
registered with www.Clinicaltrials.gov (identification number:
NCT00131040). Exclusion criteria were emergency cases, com-
bined valvular procedures or redo operations, unstable angina or
myocardial infarction within 6 weeks before surgical intervention,
cerebrovascular accident within 3 months preoperatively or more
than 75% carotid artery obstruction (as shown by carotid Doppler
scanning), serum creatinine level in excess of 177 mmol/L, coagul-
opathy, or previous use of anticoagulant/antiplatelet agents within
the week before surgical intervention. Patients who satisfied the
exclusion criteria were randomized in a double-blind study design
to receive saline infusion during bypass (group 1, n 5 7) or high-
dose (‘‘Hammersmith dose’’) aprotinin (2 3 106 KIU loading
dose, 2 3 106 KIU in the pump prime, followed by 0.5 3 106
KIU/h CPB; group 2, n 5 7). CPB was performed with aortic and
right atrial cannulation. The extracorporeal circuit consisted of
a roller pump (Stockert Instruments, Munich, Germany), a Bard
William Harvey HF-750 membrane oxygenator (C.R. Bard, Craw-
ley, England), and polyvinyl chloride tubing (non-albumin coated).
Pulsatile extracorporeal circulation was used at 2.2 to 2.4 L $m22 $
min21 to maintain a mean blood pressure of 50 to 60 mm Hg.
Moderate hypothermia of 32C to 34C was applied in all patients.
Patients received heparin (Monoparin; CP-Pharmaceuticals,
Wrexham, United Kingdom) to achieve an activated coagulation
time of greater than 480 seconds (Hemochron Jr, [International
Technidyne Corporation, Edison, NJ] using kaolin).
Cantharidin Skin Blisters
The cantharidin skin blister technique has been described in detail
previously.7 Skin blisters in duplicate were induced by means of
topical application of a 0.1% solution of Cantharone (Dormer
Laboratories) in acetone to the volar aspect of the forearm according
to the timeline depicted in Figure 1. Each blister was allowed to de-
velop for 24 hours, with perioperative blisters timed for harvest at
5 hours after the initiation of CPB. Blister fluid was collected with
siliconized pipette tips (Sigma Aldrich, Poole, United Kingdom)ay 2008
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Figure 1. Schematic illustration of the study time-
line. Reference blisters (in duplicate) were car-
ried out preoperatively to establish the normal
leukocyte extravasation response to cantharidin
(pre-op blister). These were compared with peri-
operative skin blisters (in duplicate) to gauge
the effect of coronary artery bypass grafting sur-
gery with cardiopulmonary bypass (CPB) on leu-
kocyte extravasation (peri-op blister). In total, 4
blisters were applied to each patient. Blisters
were allowed to develop for 24 hours, with blister
harvest postoperatively taking place 5 hours after
the initiation of CPB.and stored on ice in siliconized microcentrifuge tubes before flow
cytometric analysis. Cell counts were performed with Kimura’s
stain and counting in a hemocytometer. Cell-free supernatants, col-
lected after microcentrifugation, were stored at270C for enzyme-
linked immunosorbent assay (ELISA) analysis.
Flow Cytometric Analysis
CD11b and CD62L expression was monitored on gated neutrophil
and monocyte populations in whole blood and blister infiltrated
cells, according to the gating scheme depicted in Figure 2. Flow cy-
tometric analysis of blister leukocytes was performed immediately
after centrifugation of blister samples, with all incubation (15 min-
utes) and washing steps being carried out in ice-cold phosphate-
buffered saline, as previously described.13 Whole-blood samples
were prepared for staining by using the Immunolyse whole-blood
lysing technique (Beckman Coulter, Luton, United Kingdom), as
previously described.23 Primary antibody incubations were carried
out in phosphate-buffered saline at room temperature for 15 min-
utes, as per the manufacturer’s recommendations. Results are
expressed as mean fluorescent staining intensities.
ELISAs
IL-8 and TNF-a levels in blister fluid were measured in triplicate by
means of capture ELISA (R&D Systems, Abingdon, United King-
dom), according to the manufacturer’s recommendations. TNF
levels showed wide interpatient variability, and results were normal-
ized for each individual by using preoperative blisters. IL-8 levels
were expressed as the mean concentration (in nanograms per milli-
liter) 6 the standard error.
Statistical Analysis
Power studies based on a previous investigation24 of leukocyte ex-
travasation into skin blisters in healthy donors indicated that a min-
imum sample size of 5 in each group would have a greater than 90%
power to detect a difference in means of 7.503 105 cells per blister
(the difference between a group 1mean of 15.003 105 cells per blis-
ter and a group 2 mean of 7.503 105 cells per blister), assuming that
the common standard deviation was 2.8 by using a 2-group t test
with a .05 2-sided significance level.
Differences in perioperative patient characteristics between treat-
ment groups were analyzed by using distribution-free univariate
tests: the Fisher exact test for 2-level categorical data, such as sexThe Journal of Thorand diabetes prevalence; the Wilcoxon Mann–Whitney test for 3-
level categorical data, such as Canadian Cardiovascular Society
class and number of grafts; and a permutation test for continuous
data, such as age and blood loss.
All leukocyte components were log-transformed before analyses
to improve the normality of the data. After averaging results from du-
plicate blisters (there were 2 blisters per person at each time point),
differences between preoperative and perioperative leukocyte com-
ponents were assessed by using paired t tests. Treatment group dif-
ferences in perioperative leukocyte components were analyzed by
using unpaired t tests. The average values of leukocyte components
were presented as geometric means.25 Because of the small sample
size, all parametric tests were verified by using an equivalent distri-
bution-free test (the Wilcoxon matched pairs signed-rank test for
a paired t test and the Mann–Whitney U test for an unpaired t test).
Exact P values are presented at all times to clarify the strength of
the statistical relationships. Statistical analysis was performed with
Stata 9 statistical software (Stata Corp, College Station, Tex).
Results
Study Design and Group Characteristics
The study design is outlined in Figure 1. Patients scheduled
for primary elective CABG with CPB were enrolled into
the study during the presurgery clinic with institutional re-
view board approval and after providing informed consent.
Patients who satisfied the exclusion criteria were randomized
into control (saline) and aprotinin treatment groups. Study
participants were invited to book into the presurgical ward
2 days before the operation and had reference skin blisters,
in duplicate, carried out on their forearm (‘‘pre-op blister’’
in Figure 1). These blisters would serve as an internal control
to establish each person’s baseline response to cantharidin.
Perioperative skin blisters were then induced on the day be-
fore the operation and timed such that collection of blister
fluid would take place postoperatively 5 hours after the initi-
ation of CPB (‘‘peri-op blister’’ in Figure 1).
Experimental cantharidin skin blisters were well tolerated
by patients. No statistically significant differences in patient
demographics or preoperative characteristics were noted be-
tween the aprotinin and saline treatment groups (Table 1).acic and Cardiovascular Surgery c Volume 135, Number 5 1001
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CSPFigure 2. Flowcytometric dot plot of blister fluid il-
lustrating the gating strategy used to discern extra-
vascular neutrophil and monocyte subpopulations.
Neutrophils were identified and gated based on
their characteristic side-scatter profile. Mono-
cytes were identified in the mononuclear cell
(MNC) gate based on expression of CD14 in the
fluorescence (FL) 3 channel. Representative flow
histograms depict CD11b and CD62L expression
perioperatively on neutrophils and monocytes
present in blister fluid (solid line) versus the circu-
lation (filled histograms). SS, side scatter; FS,
forward scatter; LIN, linear.There was no statistically significant difference in the number
of grafts performed, bypass time, or crossclamp time. At fol-
low-up, there was significantly less blood loss (P5 .02) and
red cell transfusion (P 5 .01) in the aprotinin group. No sta-
tistically significant differences were noted for platelet trans-
fusion, serum creatinine level, or atrial fibrillation. No serious
adverse events after surgical intervention were reported in
either group (Table 1).
Leukocyte Extravasation into Skin Blisters
In the saline control group leukocyte extravasation into peri-
operative skin blisters increased from 4.84 (95% CI,
2.14–0.92) to 24.48 (95%CI, 10.30–58.16) comparedwith ref-
erence blisters harvested preoperatively (P 5 .013, Table 2),
which represents a 381% increase in leukocyte emigration in-1002 The Journal of Thoracic and Cardiovascular Surgery c Mduced by surgical intervention. Inflammatory cells recovered
from blisters were analyzed flow cytometrically by using the
gating strategy shown in Figure 2 (upper panel). Neutrophils
were resolved on the basis of their characteristic side-scatter
profile, as previously described,13 and comprised 94.6% 6
3.96% (mean 6 standard deviation) pure neutrophils
(CD161/very late antigen 4 negative) plus a residual popula-
tion of CD161/very late antigen 4–positive eosinophils.
Monocytes were resolved in the mononuclear cell gate based
on expression of the LPS receptor CD14. CD142 cells in the
mononuclear cell gate were considered lymphocytes. Analy-
sis of leukocyte subsets recovered from blister fluid (Table 2)
revealed a significant increase in neutrophils (P 5 .014),
monocytes (P 5 .014), and eosinophils (P 5 .009) traffick-
ing into the skin perioperatively in the saline-treated controlay 2008
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PTABLE 1. Perioperative patient characteristics
Treatment group
Saline Aprotinin P value
Age, y (mean [SD]) 65.6 (6.4) 61.0 (10.8) .39z
Sex (% male) 100 71 .46*








EF (% good) 71 100 .46*
Previous MI (%) 57 43 .99*
Current smoker (%) 0 14 .99*
Current or past smoke (%) 100 71 .46*
Diabetes (%) 14 57 .27*






76.4 (6.2) 75.7 (5.2) .95z
Crossclamp time,
min (mean [SD])
43.0 (6.9) 40.3 (2.8) .79z
Blood loss 24 h, mL
(mean [SD])
1142 (531) 586 (112) .02z
RBC, U (mean [SD]) 2.5 (1.3) 0.3 (0.5) .01z
Platelets (% present) 50 0 .13*
Creatinine, mmol/L
(mean [SD])




SD, Standard deviation; CCS, Canadian Cardiovascular Society; NYHA, New
York Heart Association; EF, ejection fraction;MI, myocardial infarction; CPB,
cardiopulmonary bypass; RBC, red blood cells. *Fisher exact test.
yWilcoxon Mann–Whitney test for categorical data. zPermutation test.The Journal of Thoragroup of patients undergoing CPB. In contrast, none of these
inflammatory leukocyte subsets was statistically significantly
increased during surgical intervention in the aprotinin-treated
group (Table 2).
Phenotypic Analysis of Emigrated Leukocytes
The activation phenotype of neutrophils and monocytes infil-
trating into blisters was investigated further by comparing
CD11b/CD62L expression with the corresponding leukocyte
phenotype in blood. Representative flow cytometric histo-
grams (Figure 2, lower panels) depict the upregulation of
CD11b (CR3; Mac-1) and shedding of CD62L (L-selectin)
receptor on neutrophil and monocyte subpopulations seen
during their emigration from blood into blisters. These phe-
notypic changes, considered a hallmark of leukocyte activa-
tion during extravasation,15,23 were significant on both
neutrophil and monocyte subsets, regardless of treatment
group or preoperative versus perioperative time points (Table
3). Thus whereas anti-inflammatory intervention with aproti-
nin prevented operation-induced neutrophil and monocyte
trafficking into the skin, the activation status of emigrated
leukocytes at 5 hours after the operation was not changed.
Inflammatory Mediators in Blister Fluid
IL-8 and TNF-a are examples of inflammatory cytokines that
are implicated in organ injury after CPB.26,27 Levels of both
cytokines were significantly reduced in perioperative skin
blisters in the aprotinin versus saline groups (P 5 .044 for
IL-8 and P 5 .004 for TNF-a, Figure 3).
Discussion
The present study establishes the cantharidin skin blister tech-
nique as a novel translational tool capable of monitoring the
inflammatory effect of cardiothoracic surgery on leukocyte
extravasation. By combining the technique with flow
cytometric analysis, we have been able to demonstrate for











Total leukocytes 4.84 (2.14–10.92)* 24.48 (10.30–58.16) .013 .043 7.52 (2.48–22.83) 10.28 (4.31–24.49) .470 .499
Neutrophils 2.79 (1.21–6.44) 14.37 (5.64–36.65) .014 .028 4.37 (1.41–13.53) 5.18 (2.11–12.71)y .724 .735
Monocytes 1.16 (0.51–2.67) 6.37 (2.80–14.49) .014 .028 1.70 (0.52–5.53) 2.93 (1.13–7.56) .277 .311
Eosinophils 0.40 (0.18–0.86) 1.73 (0.77–3.92) .009 .018 0.76 (0.26–2.18) 1.25 (0.52–3.01) .266 .237
Lymphocytes 0.40 (0.16–1.01) 1.02 (0.41–2.53) .093 .063 0.58 (0.24–1.42) 0.60 (0.22–1.59) .972 .499
*Geometric mean (95% confidence interval); 3 105 cells per blister. yExtravasation of the neutrophil subpopulation into skin perioperatively was marginally
inhibited comparing aprotinin versus saline (14.373 105 cells per blister after saline and 5.183 105 cells per blister after aprotinin: P5 .086, unpaired t test;
P5 .110, Mann–Whitney test). The same trend was observed for the other leukocyte subsets but was not statistically significant (monocytes: P5 .172 [t test],
P5 .142 [Mann–Whitney test]; eosinophils: P5 .568 [t test], P5 .565 [Mann–Whitney test]; and lymphocytes: P5 .357 [t test], P5 .277 [Mann–Whitney test]).
Overall, the total leukocyte count was marginally inhibited comparing aprotinin versus saline (24.483 105 cells per blister after saline and 10.283 105 cells per
blister after aprotinin: P 5 .116, unpaired t test; P 5 .142, Mann–Whitney test).cic and Cardiovascular Surgery c Volume 135, Number 5 1003
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CSPmigration of each of the major inflammatory leukocyte sub-
sets: neutrophils, monocytes, and eosinophils. Aprotinin at-
tenuated leukocyte extravasation and inflammatory cytokine
(IL-8 and TNF-a) accumulation in blister fluid, thus validat-
ing the cantharidin technique as a tool for analyzing anti-
inflammatory interventions in cardiothoracic surgery.
TABLE 3. Fluorescent intensity of CD11b and CD62L on
neutrophil and monocyte subsets
Saline Aprotinin
Blood MFI Blister MFI Blood MFI Blister MFI
Neutrophil CD11b
Preop 1.0 (0.9)* 54.0 (26.5) 2.9 (2.1) 63.9 (37.7)
Periop 0.8 (0.5) 50.8 (28.7) 1.4 (1.0) 54.5 (34.1)
Neutrophil CD62L
Preop 97.8 (1.5)y 20.6 (24.2) 98.9 (0.6) 37.4 (25.2)
Periop 97.5 (2.0) 32.7 (14.9) 96.8 (5.5) 57.1 (17.1)
Monocyte CD11b
Preop 0.4 (0) 24.3 (13.6) 0.8 (0.6) 32.8 (22.7)
Periop 0.4 (0.1) 26.3 (18.8) 0.6 (0.2) 37.5 (26.9)
Monocyte CD62L
Preop 61.4 (18.0) 2.0 (2.8) 73.5 (14.3) 13.7 (13.8)
Periop 74.3 (17.0) 1.2 (1.0) 93.5 (14.1) 11.4 (10.9)
MFI, Mean fluorescent intensity (log10). *Mean (standard deviation) CD11b
expression was statistically significantly increased on leukocytes recov-
ered from blister fluid compared with values in blood, regardless of leuko-
cyte subtype, preoperative or perioperative time point, or treatment group
(P , .004, paired t test, in all cases, remaining statistically significant after
the Bonferroni correction). yCD62L expression was significantly decreased
(indicative of shedding) on leukocytes recovered from blister fluid compared
with values in blood, regardless of leukocyte subtype, preoperative or
perioperative time point, or treatment group (P , .0001, paired t test, in all






























Figure 3. Interleukin (IL) 8 and tumor necrosis factor (TNF)a levels
in perioperative blister fluid. TNF-a levels were normalized for
each individual relative to preoperative blisters. Results are
expressed as the means 6 standard deviation.1004 The Journal of Thoracic and Cardiovascular Surgery c MDespite the importance of extravascular leukocytes in the
pathogenesis of organ injury after CPB, this has been a diffi-
cult area to study clinically. Although multiple studies have
examined systemic markers of leukocyte activation and sys-
temic inflammatory mediators, these have provided no real
insight into the extravascular pool of leukocytes likely to
be involved in organ injury. Bronchoalveolar lavage (BAL)
fluid is an accessible and clinically relevant extravascular
compartment for study but is complicated by the fact that em-
igrated leukocyte populations can be masked by large resi-
dent pools of cells. Studies of BAL fluid have reported
accumulation of emigrated neutrophils after CPB.26,28 The
present study confirms and extends this work. We demon-
strate that neutrophils after surgical intervention (as a percent-
age) comprise 65.2% 6 19.5% of total leukocytes in blister
fluid. This is greater than previously reported in BAL fluid
after surgical intervention (30.5% 6 12.5% and 11.3% 6
12.2%),26,28 but the smaller neutrophil component in BAL
fluid might have been due to the presence of contaminating
resident cells in lavage fluid. Our study reinforces the belief
that neutrophils play a central role in the pathophysiology
of inflammatory organ injury.29
Monocytes were the next most abundant tissue-infiltrating
cell type (24.1% 6 6.6% of total leukocytes in the saline
group perioperatively), with the remainder consisting of eo-
sinophils (6.5% 6 2.0%) and lymphocytes (4.2% 6 1.0%).
Monocytes are known to be activated systemically after by-
pass,30 but the observation that these cells emigrate in signif-
icant numbers into tissues provides new evidence for
a pathogenic role after CPB. Trafficking of activated mono-
cytes, which are a primary source of TNF-a, might be of par-
ticular relevance to neurologic injury after cardiac surgery
because TNF-a causes focal ischemic brain injury through
inducing apoptosis.31
The present study has also validated cantharidin skin blis-
ters as a tool for monitoring a given anti-inflammatory inter-
vention in cardiothoracic surgery. We present the first in vivo
evidence that aprotinin prevents on-pump operation-induced
leukocyte extravasation, a mechanism previously imputed
from in vitro and animal studies.19-22 Inflammatory cytokine
(IL-8 and TNF-a) accumulation was also significantly in-
hibited by aprotinin. These findings are in agreement with ob-
servations in BAL fluid, which reported reduced IL-8 levels
in patients receiving aprotinin during CPB surgery.26 The
combined reduction of inflammatory leukocyte trafficking
and proinflammatory cytokine accumulation in skin suggests
that these properties of aprotinin might contribute to its neu-
roprotective mechanism of action demonstrated in placebo-
controlled trials.17,18,32
The present study was not powered to investigate possible
adverse clinical reactions caused by aprotinin administra-
tion.33,34 Nevertheless, we report no serious adverse events
in either treatment group. One patient in the aprotinin group
and 2 patients in the saline group had peak serum creatinineay 2008
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Pvalues of greater than 200 mmol/L, but no patient required
dialysis. Patients in the aprotinin group had significantly
reduced blood loss and red cell transfusion requirement, con-
firming the hemostatic efficacy of aprotinin. The failure of
aprotinin to suppress leukocyte activation in the present study
appears at odds with other studies showing inhibition of
CD11b by aprotinin on neutrophils examined at earlier
time points (15–30 minutes after initiation of bypass).15,23
Differences might have been due to the relatively late time
point (5 hours postoperatively) of sampling here or the fact
that cantharidin skin blisters are intrinsically inflammatory.
The intrinsic inflammatory nature of topical cantharidin is
a limitation of the study. What is being sampled postopera-
tively is a composite of a systemic inflammatory response
caused by surgical intervention and a local inflammatory
response caused by cantharidin. Nonetheless, surgical inter-
vention with CPB triggered a robust increase in extravasated
leukocytes (381% compared with reference blisters carried
out preoperatively), and this increment was ablated with
anti-inflammatory intervention. Because this is the first study
to use the cantharidin technique in a surgical setting, it is too
early to say whether leukocyte infiltration or cytokine accu-
mulation is correlated with clinical events. Further studies ad-
equately powered to address clinical outcomes would be
needed to address this issue. Another limitation is the ques-
tion of how valid it is to extrapolate anti-inflammatory effects
observed in the skin to organs affected by the inflammatory
response to CPB. Ideally, one would want a technique for
monitoring leukocyte infiltration directly into, for example,
the human brain, lung, and kidneys. The value of the canthar-
idin skin test is that it provides novel molecular insight into
the pool of leukocytes migrating extravascularly during the
operation, which is poorly understood at present.
In conclusion, we have established a new technique for
monitoring the extravascular leukocyte population in cardio-
thoracic surgery. This technique might be a useful research
tool to evaluate future anti-inflammatory interventions in
cardiothoracic surgery.
We thank Dr Pete Anning at Scienceposters.co.uk for expert
assistance with the figures.
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